Martin Shkreli, the drug entrepreneur who defended his decision to raise the price of a life-saving AIDS drug from $13.50 to $750, went quiet Thursday at a Congressional committee, grinning instead of ...
Turing Pharmaceuticals CEO Martin Shkreli on Friday defended, without apology, his decision to up the price of the drug Daraprim from $3.50 a pill to $750, during an online interview Friday at ...
In 2015, Martin Shkreli captured national headlines when he raised the price of a life-saving medication by 5,000%—from $13.50 to $750 per pill. But the audacious price hike wasn't what ultimately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback